In the tumor-draining lymph node, activated APC, e.g., dendritic cells (DCs), present tumor antigens on their major histocompatibility complex (MHC) class I to CD8+ T cells and on MHC class II to CD4+ T cells. The gene discussed is CD8A; the disease is neoplasm.